Clinical Trial Update: Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial [Phase 2, Phase 3]

View source ↗

Summary

Recruitment is ongoing for a Phase 2/3 randomized trial evaluating a triple artemisinin-based combination therapy aimed at delaying drug resistance in uncomplic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Triple Artemisinin-based Combination Therapy

Snippet

Sponsor: Muhimbili University of Health and Allied Sciences | Conditions: Uncomplicated Plasmodium Falciparum Malaria | Phase 2, Phase 3 | Status: RECRUITING